astrazeneca glp-1 glp 1 drug AstraZeneca's oral obesity Elecoglipron has advanced to Phase III clinical trials after AstraZeneca's ECC5004: Pioneering oral GLP-1RA
Pay in 4 interest-free payments of $5.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10

























